KT-939

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameKT-939
Drug Alias NameKT-939
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosinase inhibitors
TargetsTyrosinase
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKaituo Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A